midodrine and Multiple Hemangioblastomas
midodrine has been researched along with Multiple Hemangioblastomas in 1 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Jabary, NS | 1 |
Sarabia, R | 1 |
Sanchez, T | 1 |
Gordillo, R | 1 |
Other Studies
1 other study available for midodrine and Multiple Hemangioblastomas
Article | Year |
---|---|
Midodrine treatment in the management of severe orthostatic hypotension after hemangioblastoma surgery.
Topics: Cerebral Ventricle Neoplasms; Drug Administration Schedule; Female; Foramen Magnum; Fourth Ventricle | 2007 |